A secretagogue is a substance that stimulates a cell or gland to release a product. The term describes an action, not a chemical family. A secretagogue may be a peptide or another kind of molecule, and the released substance may be a hormone or another biological material.

Stimulating release differs from replacement

Giving a hormone supplies that hormone directly. A secretagogue instead acts on a system capable of releasing it. The response can depend on the condition of the gland, receptor activity and other regulatory signals.

Ghrelin provides an instructive example. Its identification as a naturally occurring stomach-derived peptide with growth-hormone-releasing activity connected a previously studied receptor system with an endogenous signal. Kojima and colleagues, Nature, 1999

The word does not specify selectivity

A substance can stimulate one response while affecting other processes. The amount released may also vary with physiological conditions. “Secretagogue” therefore does not mean “precisely controlled,” “safer than replacement,” or “free of side effects.”

Similarly, a laboratory release assay answers a narrower question than a clinical trial. It can show that cells respond, but not whether the response improves a person’s health.

How to read the term in a study

Identify which cells are being stimulated, what is released and which receptor or pathway is involved. Then distinguish the immediate biochemical response from downstream outcomes. For growth-hormone research, changes in GH or IGF-1 are not equivalent to demonstrated benefits in strength, recovery or lifespan.

Secretagogue is useful vocabulary because it clarifies a mechanism. It should not be used as a reassuring label that bypasses the need to establish product identity, exposure, safety and meaningful clinical benefit.